465 related articles for article (PubMed ID: 31134525)
1. Modeling neuropsychiatric disorders using human induced pluripotent stem cells.
Wang M; Zhang L; Gage FH
Protein Cell; 2020 Jan; 11(1):45-59. PubMed ID: 31134525
[TBL] [Abstract][Full Text] [Related]
2. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
[TBL] [Abstract][Full Text] [Related]
3. Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells.
van Hugte E; Nadif Kasri N
Adv Exp Med Biol; 2019; 1192():297-312. PubMed ID: 31705501
[TBL] [Abstract][Full Text] [Related]
4. Reaching into the toolbox: Stem cell models to study neuropsychiatric disorders.
Whiteley JT; Fernandes S; Sharma A; Mendes APD; Racha V; Benassi SK; Marchetto MC
Stem Cell Reports; 2022 Feb; 17(2):187-210. PubMed ID: 35063127
[TBL] [Abstract][Full Text] [Related]
5. Modeling psychiatric disorders with patient-derived iPSCs.
Wen Z; Christian KM; Song H; Ming GL
Curr Opin Neurobiol; 2016 Feb; 36():118-27. PubMed ID: 26705693
[TBL] [Abstract][Full Text] [Related]
6. In vitro models for ASD-patient-derived iPSCs and cerebral organoids.
Hohmann SS; Ilieva M; Michel TM
Prog Mol Biol Transl Sci; 2020; 173():355-375. PubMed ID: 32711817
[TBL] [Abstract][Full Text] [Related]
7. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Recapitulation of Neuropsychiatric Disorders with Pluripotent Stem Cells-Derived Brain Organoids.
Gulimiheranmu M; Li S; Zhou J
Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886158
[TBL] [Abstract][Full Text] [Related]
9. Modeling neurodevelopmental and psychiatric diseases with human iPSCs.
Wen Z
J Neurosci Res; 2017 May; 95(5):1097-1109. PubMed ID: 28186671
[TBL] [Abstract][Full Text] [Related]
10. The promises and challenges of human brain organoids as models of neuropsychiatric disease.
Quadrato G; Brown J; Arlotta P
Nat Med; 2016 Nov; 22(11):1220-1228. PubMed ID: 27783065
[TBL] [Abstract][Full Text] [Related]
11. Patient-Derived Induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids for Drug Screening and Development in Autism Spectrum Disorder: Opportunities and Challenges.
Villa C; Combi R; Conconi D; Lavitrano M
Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33669772
[TBL] [Abstract][Full Text] [Related]
12. Psychiatry in a Dish: Stem Cells and Brain Organoids Modeling Autism Spectrum Disorders.
Ilieva M; Fex Svenningsen Å; Thorsen M; Michel TM
Biol Psychiatry; 2018 Apr; 83(7):558-568. PubMed ID: 29295738
[TBL] [Abstract][Full Text] [Related]
13. Human stem cell-based models for studying autism spectrum disorder-related neuronal dysfunction.
Cheffer A; Flitsch LJ; Krutenko T; Röderer P; Sokhranyaeva L; Iefremova V; Hajo M; Peitz M; Schwarz MK; Brüstle O
Mol Autism; 2020 Dec; 11(1):99. PubMed ID: 33308283
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system organoids for modeling neurodegenerative diseases.
Hou PS; Kuo HC
IUBMB Life; 2022 Aug; 74(8):812-825. PubMed ID: 35102668
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomics analysis of iPSC-derived neurons and modeling of neuropsychiatric disorders.
Lin M; Lachman HM; Zheng D
Mol Cell Neurosci; 2016 Jun; 73():32-42. PubMed ID: 26631648
[TBL] [Abstract][Full Text] [Related]
16. Pluripotent stem cells in neuropsychiatric disorders.
Soliman MA; Aboharb F; Zeltner N; Studer L
Mol Psychiatry; 2017 Sep; 22(9):1241-1249. PubMed ID: 28322279
[TBL] [Abstract][Full Text] [Related]
17. What Have Organoids and Assembloids Taught Us About the Pathophysiology of Neuropsychiatric Disorders?
Levy RJ; Paşca SP
Biol Psychiatry; 2023 Apr; 93(7):632-641. PubMed ID: 36739210
[TBL] [Abstract][Full Text] [Related]
18. Development and Application of Brain Region-Specific Organoids for Investigating Psychiatric Disorders.
Zhang Z; Wang X; Park S; Song H; Ming GL
Biol Psychiatry; 2023 Apr; 93(7):594-605. PubMed ID: 36759261
[TBL] [Abstract][Full Text] [Related]
19. Understanding neurodevelopmental disorders using human pluripotent stem cell-derived neurons.
Tamburini C; Li M
Brain Pathol; 2017 Jul; 27(4):508-517. PubMed ID: 28585386
[TBL] [Abstract][Full Text] [Related]
20. Opportunities and limitations for studying neuropsychiatric disorders using patient-derived induced pluripotent stem cells.
Hong Y; Yang Q; Song H; Ming GL
Mol Psychiatry; 2023 Apr; 28(4):1430-1439. PubMed ID: 36782062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
